Doesn't seem likely.
China appears keen to decrease their reliance on Australia for IO and have re focused their attention on places like Africa.
Indications are they are prepared to contribute large amounts of capital for development and ensure ownership of a large supply chain. They don't appear too concerned about the projects various profitability as long as they can bring the price down and control at least part supply, which of course will impact the global IO market.
Interesting to see how it all evolves, but I still think Aus IO will be in demand as a reliable and high quality supply and also in other parts of the world.
If Todd have missed the chinese funding window, who is now prepared to fund new development areas to increase Aus production or fund for replacement resource areas?
As we have said before, our majority ownership may be a deterrent and wouldn't surprise me if many eyes are watching current events (or should I say non events) with interest!
- Forums
- ASX - By Stock
- RHK
- Chinas Cornerstone Plans
Chinas Cornerstone Plans, page-2
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RHK (ASX) to my watchlist
|
|||||
Last
84.5¢ |
Change
0.040(4.97%) |
Mkt cap ! $168.8M |
Open | High | Low | Value | Volume |
84.5¢ | 84.5¢ | 84.5¢ | $95 | 112 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 5 | 80.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
88.0¢ | 10355 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 5 | 0.805 |
1 | 3035 | 0.800 |
1 | 2531 | 0.770 |
1 | 16200 | 0.760 |
2 | 5573 | 0.740 |
Price($) | Vol. | No. |
---|---|---|
0.880 | 10355 | 1 |
0.890 | 2368 | 1 |
0.910 | 20000 | 1 |
0.980 | 10000 | 1 |
1.000 | 1812 | 2 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
RHK (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online